Press Releases
CergenX achieves CE Mark for pioneering AI technology designed to transform newborn brain assessment | MedTech Dive
Irish medical technology company CergenX announced on September 1, 2026, that its first product, Wave, has received EU CE marking certification. Wave combines electroencephalography (EEG) and artificial intelligence technology to provide clinicians with objective assessment results of neonatal brain activity and abnormalities related to brain injury in approximately 30 seconds. The company states that over one million newborns worldwide are affected by brain injury each year, and more than 80% of hospitals globally lack access to EEG examination and interpretation services. Wave aims to lower the professional barrier, making expert-level neonatal brain assessment more accessible.
ACTO Achieves Veeva Gold Product Partner Status, Following a Nearly Decade-Long Collaboration Supporting Mutual Customer Success | MedTech Dive
ACTO announces its achievement of Veeva Gold Product Partner status, continuing nearly a decade of collaboration, enhancing training, practice, and execution efficiency for frontline teams in the life sciences through Veeva-validated integrations.